Searched for
TALTZ
Reduce Sun Pharmaceutical Industries, target Rs 450: IIFLReduce Sun Pharmaceutical Industries at a price target of Rs 450.- Decoding the impact of Ilumya, Sun Pharma's first biologic drug approved by the US FDALast year Sun Pharma signed another deal with South Korea's Samsung Biologics to get the drug manufactured on approval.
- Tildra approval to give sentimental push to Sun PharmaThe drug which will be sold under the brand name Ilumya is expected to treat adults for moderate to severe plaque psoriasis, an autoimmune ...
- You're running out of good names for your companyThere is a numeric limit to the universe of names, the combinations of letters of five syllables or less that are pronounceable, avoid offe...
- Sun Pharma signs licening pact with spanish firm Almirall for psoriasis drugIn return, the Indian company will receive an initial upfront payment of $50 million and be eligible for development and regulatory milesto...
Load More